Unreported / Non-Citable
Background
Investors who bought Simple Agreements for Future Equity, commonly called SAFE notes, sued LifeVoxel and its principals for federal securities fraud. They alleged misstatements and omissions about finances, prior capitalization, and plans involving minority shares. The district court dismissed because the investors had not plausibly connected the alleged fraud to an actual loss.
The district court also reasoned that SAFE-note holders could show economic loss only if a future conversion event had become impossible. It denied further leave to amend. The investors appealed both the dismissal and that restrictive view of how a private, nontraded instrument can lose value.
The Court’s Holding
The Ninth Circuit agreed that the existing complaint inadequately pleaded economic loss and loss causation. Paying an inflated price is not by itself a recoverable securities-fraud loss. The investors needed facts showing that their investment declined in value and that a qualifying misstatement or omission was a substantial cause, separated from mismanagement and the other forces affecting company value.
But the district court demanded too much by requiring conversion to become impossible. A SAFE note can decline in present value even if conversion remains possible, and privately traded instruments undergo the same basic loss-causation analysis despite the harder valuation proof. The panel therefore affirmed dismissal but reversed denial of leave to amend so the investors could try to plead a fraud-caused decline in value.
Key Takeaways
- SAFE-note investors do not have to allege that conversion is impossible to show economic loss.
- They must still allege an actual decline in value, not merely an inflated purchase price or possible future harm.
- The complaint must connect that decline substantially to actionable misrepresentations rather than business mistakes or general market factors.
- Private-company securities may require valuation evidence that a public market would otherwise supply.
Why It Matters
The decision offers California startup investors and founders useful guidance on securities claims involving SAFEs and other private instruments. Lack of a quoted market price does not make loss impossible, but it raises the pleading and proof burden. Counsel should identify a defensible valuation method, the timing of corrective information, and facts isolating fraud from ordinary startup risk.